ClinicalTrials.gov record
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
ClinicalTrials.gov ID: NCT02175771
Public ClinicalTrials.gov record NCT02175771. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-Week Open-Label Study to Assess the Long-Term Safety of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients 12 Years of Age and Older With Persistent Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to evaluate the long-term safety of fluticasone propionate (Fp) inhalation powder in 2 strengths and fluticasone propionate/salmeterol inhalation (FS) powder in 2 strengths when administered with the Teva multidose dry powder inhaler (MDPI) device over 26 weeks in patients with persistent asthma.
Study identification
- NCT ID
- NCT02175771
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 758 participants
Conditions and interventions
Conditions
Interventions
- Fp MDPI Drug
- FS MDPI Drug
- FLOVENT HFA Drug
- ADVAIR DISKUS Drug
- albuterol/salbutamol HFA Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2014 (Type not available)
- Primary completion
- Jul 2015 (Actual)
- Completion
- Jul 2015 (Actual)
- Last update posted
- Nov 9, 2021
2014 – 2015
United States locations
- U.S. sites
- 101
- U.S. states
- 35
- U.S. cities
- 88
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 12068 | Birmingham | Alabama | — | — |
| Teva Investigational Site 12112 | Mobile | Alabama | — | — |
| Teva Investigational Site 12130 | Pell City | Alabama | — | — |
| Teva Investigational Site 12119 | Little Rock | Alaska | — | — |
| Teva Investigational Site 12076 | Phoenix | Arizona | — | — |
| Teva Investigational Site 12135 | Scottsdale | Arizona | — | — |
| Teva Investigational Site 12132 | Tucson | Arizona | — | — |
| Teva Investigational Site 12102 | Fountain Valley | California | — | — |
| Teva Investigational Site 12104 | Fresno | California | — | — |
| Teva Investigational Site 12123 | Fullerton | California | — | — |
| Teva Investigational Site 12103 | Huntington Beach | California | — | — |
| Teva Investigational Site 12073 | Long Beach | California | — | — |
| Teva Investigational Site 12077 | Mission Viejo | California | — | — |
| Teva Investigational Site 12098 | Napa | California | — | — |
| Teva Investigational Site 12149 | Northridge | California | — | — |
| Teva Investigational Site 12081 | Orange | California | — | — |
| Teva Investigational Site 12100 | Rancho Mirage | California | — | — |
| Teva Investigational Site 12133 | Riverside | California | — | — |
| Teva Investigational Site 12146 | Riverside | California | — | — |
| Teva Investigational Site 12075 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 12074 | San Diego | California | — | — |
| Teva Investigational Site 12150 | San Diego | California | — | — |
| Teva Investigational Site 12064 | San Jose | California | — | — |
| Teva Investigational Site 12061 | Stockton | California | — | — |
| Teva Investigational Site 12141 | Walnut Creek | California | — | — |
| Teva Investigational Site 12043 | Denver | Colorado | — | — |
| Teva Investigational Site 12051 | Denver | Colorado | — | — |
| Teva Investigational Site 12091 | Waterbury | Connecticut | — | — |
| Teva Investigational Site 12078 | Fort Lauderdale | Florida | — | — |
| Teva Investigational Site 12140 | Hialeah | Florida | — | — |
| Teva Investigational Site 12066 | Kissimmee | Florida | — | — |
| Teva Investigational Site 12120 | Miami | Florida | — | — |
| Teva Investigational Site 12127 | Miami | Florida | — | — |
| Teva Investigational Site 12148 | Miami | Florida | — | — |
| Teva Investigational Site 12114 | Ocala | Florida | — | — |
| Teva Investigational Site 12055 | Sarasota | Florida | — | — |
| Teva Investigational Site 12048 | Tallahassee | Florida | — | — |
| Teva Investigational Site 12122 | Tamarac | Florida | — | — |
| Teva Investigational Site 12086 | Winter Park | Florida | — | — |
| Teva Investigational Site 12111 | Gainesville | Georgia | — | — |
| Teva Investigational Site 12070 | Lawrenceville | Georgia | — | — |
| Teva Investigational Site 12072 | Marietta | Georgia | — | — |
| Teva Investigational Site 12106 | Coeur d'Alene | Idaho | — | — |
| Teva Investigational Site 12117 | Eagle | Idaho | — | — |
| Teva Investigational Site 12065 | River Forest | Illinois | — | — |
| Teva Investigational Site 12059 | Shiloh | Illinois | — | — |
| Teva Investigational Site 12056 | Overland Park | Kansas | — | — |
| Teva Investigational Site 12138 | Fort Mitchell | Kentucky | — | — |
| Teva Investigational Site 12092 | Owensboro | Kentucky | — | — |
| Teva Investigational Site 12087 | Covington | Louisiana | — | — |
| Teva Investigational Site 12095 | Bangor | Maine | — | — |
| Teva Investigational Site 12042 | Baltimore | Maryland | — | — |
| Teva Investigational Site 12124 | Baltimore | Maryland | — | — |
| Teva Investigational Site 12052 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 12139 | Minneapolis | Minnesota | — | — |
| Teva Investigational Site 12137 | Plymouth | Minnesota | — | — |
| Teva Investigational Site 12079 | Columbia | Missouri | — | — |
| Teva Investigational Site 12067 | Rolla | Missouri | — | — |
| Teva Investigational Site 12057 | St Louis | Missouri | — | — |
| Teva Investigational Site 12060 | St Louis | Missouri | — | — |
| Teva Investigational Site 12108 | St Louis | Missouri | — | — |
| Teva Investigational Site 12128 | Warrensburg | Missouri | — | — |
| Teva Investigational Site 12136 | Bellevue | Nebraska | — | — |
| Teva Investigational Site 12115 | Las Vegas | Nevada | — | — |
| Teva Investigational Site 12131 | Las Vegas | Nevada | — | — |
| Teva Investigational Site 12126 | Ocean City | New Jersey | — | — |
| Teva Investigational Site 12129 | Verona | New Jersey | — | — |
| Teva Investigational Site 12058 | Rochester | New York | — | — |
| Teva Investigational Site 12113 | Rockville Centre | New York | — | — |
| Teva Investigational Site 12047 | Charlotte | North Carolina | — | — |
| Teva Investigational Site 12085 | Charlotte | North Carolina | — | — |
| Teva Investigational Site 12144 | Winston-Salem | North Carolina | — | — |
| Teva Investigational Site 12053 | Canton | Ohio | — | — |
| Teva Investigational Site 12094 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12105 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 12107 | Sylvania | Ohio | — | — |
| Teva Investigational Site 12069 | Tiffin | Ohio | — | — |
| Teva Investigational Site 12045 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12080 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12083 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 12062 | Eugene | Oregon | — | — |
| Teva Investigational Site 12097 | Medford | Oregon | — | — |
| Teva Investigational Site 12049 | Portland | Oregon | — | — |
| Teva Investigational Site 12134 | Bryn Mawr | Pennsylvania | — | — |
| Teva Investigational Site 12090 | Philadelphia | Pennsylvania | — | — |
| Teva Investigational Site 12089 | Providence | Rhode Island | — | — |
| Teva Investigational Site 12088 | Warwick | Rhode Island | — | — |
| Teva Investigational Site 12096 | Charleston | South Carolina | — | — |
| Teva Investigational Site 12147 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 12121 | Dallas | Texas | — | — |
| Teva Investigational Site 12099 | El Paso | Texas | — | — |
| Teva Investigational Site 12071 | Live Oak | Texas | — | — |
| Teva Investigational Site 12054 | San Antonio | Texas | — | — |
| Teva Investigational Site 12145 | Waco | Texas | — | — |
| Teva Investigational Site 12046 | Murray | Utah | — | — |
| Teva Investigational Site 12041 | South Burlington | Vermont | — | — |
| Teva Investigational Site 12125 | Richmond | Virginia | — | — |
| Teva Investigational Site 12101 | Seattle | Washington | — | — |
| Teva Investigational Site 12109 | Spokane | Washington | — | — |
| Teva Investigational Site 12044 | Tacoma | Washington | — | — |
| Teva Investigational Site 12082 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02175771, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02175771 live on ClinicalTrials.gov.